nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of outcomes between transperitoneal and retroperitoneal robotic assisted partial nephrectomy in patients with completely endophytic kidney tumors
|
Okhawere, Kennedy E. |
|
|
41 |
2 |
p. 111.e1-111.e6 |
artikel |
2 |
Applicant perceptions of virtual interviews for society of urologic oncology fellowships during the COVID-19 pandemic
|
Gore, John L. |
|
|
41 |
2 |
p. 65-68 |
artikel |
3 |
A Tribute to Allen
|
Droller, Michael J. |
|
|
41 |
2 |
p. 53-57 |
artikel |
4 |
Bladder cancer is associated with decreased urinary microbiota diversity and alterations in microbial community composition
|
Hrbáček, Jan |
|
|
41 |
2 |
p. 107.e15-107.e22 |
artikel |
5 |
Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis
|
Alshalalfa, Mohammed |
|
|
41 |
2 |
p. 106.e17-106.e23 |
artikel |
6 |
Collecting duct carcinoma: Epidemiology, clinical characteristics and survival
|
Panunzio, Andrea |
|
|
41 |
2 |
p. 110.e7-110.e14 |
artikel |
7 |
Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship
|
Hensley, Patrick J. |
|
|
41 |
2 |
p. 108.e11-108.e17 |
artikel |
8 |
Conductive hyperthermic chemotherapy versus electromotive drug administration of mitomycin C as intravesical adjuvant treatment of patients with intermediate or high-risk non-muscle invasive bladder cancer
|
Melgarejo Segura, María Teresa |
|
|
41 |
2 |
p. 109.e1-109.e8 |
artikel |
9 |
Cover 2 - Masthead
|
|
|
|
41 |
2 |
p. IFC |
artikel |
10 |
COVID-19 Seminars Issue 2 – Introduction
|
Gore, John L. |
|
|
41 |
2 |
p. 69 |
artikel |
11 |
Editorial Board
|
|
|
|
41 |
2 |
p. i |
artikel |
12 |
Financial toxicity in prostate cancer survivors: A national cross-sectional assessment of subjective financial burden
|
Herrera, Christopher D. |
|
|
41 |
2 |
p. 105.e1-105.e8 |
artikel |
13 |
Functional outcomes after prostate cancer treatment: A comparison between single and multiple modalities
|
Muise, Alexandra |
|
|
41 |
2 |
p. 104.e1-104.e9 |
artikel |
14 |
Humanization in oncology care: A necessary change
|
Diaz, Kevin A. |
|
|
41 |
2 |
p. 58-61 |
artikel |
15 |
Implementation of a comprehensive prehabilitation program for patients undergoing radical cystectomy
|
Smelser, Woodson W. |
|
|
41 |
2 |
p. 108.e19-108.e27 |
artikel |
16 |
Increasing the value of PSA through improved implementation
|
Lange, Suzanne |
|
|
41 |
2 |
p. 96-103 |
artikel |
17 |
Interaction of MRI and active surveillance in prostate cancer: Time to re-evaluate the active surveillance inclusion criteria
|
Venderbos, Lionne DF |
|
|
41 |
2 |
p. 82-87 |
artikel |
18 |
Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening
|
Carlsson, Sigrid V. |
|
|
41 |
2 |
p. 76-77 |
artikel |
19 |
Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
|
Alsyouf, Muhannad |
|
|
41 |
2 |
p. 109.e9-109.e14 |
artikel |
20 |
MRI versus non-MRI diagnostic pathways before radical prostatectomy: Impact on nerve-sparing, positive surgical margins, and biochemical recurrence
|
Patel, Hiten D. |
|
|
41 |
2 |
p. 104.e19-104.e27 |
artikel |
21 |
Novel synthetic lethality drug target in urothelial bladder cancer based on MTAP genomic loss
|
Basin, Michael F. |
|
|
41 |
2 |
p. 109.e15-109.e22 |
artikel |
22 |
Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder
|
Rahman, Syed N. |
|
|
41 |
2 |
p. 107.e1-107.e8 |
artikel |
23 |
Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence
|
Perera, Marlon |
|
|
41 |
2 |
p. 105.e19-105.e23 |
artikel |
24 |
Palliative care knowledge, attitudes, and experiences amongst patients with bladder cancer and their caregivers
|
Filippou, Pauline |
|
|
41 |
2 |
p. 108.e1-108.e9 |
artikel |
25 |
Predicting short- and long-term renal function following partial and radical nephrectomy
|
Roussel, Eduard |
|
|
41 |
2 |
p. 110.e1-110.e6 |
artikel |
26 |
Predictive value of low testosterone concentrations during and prior to enzalutamide treatment in metastatic castration-resistant prostate cancer
|
van Winden, Lennart J. |
|
|
41 |
2 |
p. 104.e11-104.e17 |
artikel |
27 |
PSA testing, cancer treatment, and prostate cancer mortality reduction: What is the mechanism?
|
Albertsen, Peter C. |
|
|
41 |
2 |
p. 78-81 |
artikel |
28 |
Radical prostatectomy readmissions: Causes, risk factors, national rates, & costs
|
Balasubramanian, Shiva |
|
|
41 |
2 |
p. 106.e1-106.e8 |
artikel |
29 |
Recurrence patterns in bladder cancer patients with no residual disease (pT0N0) at radical cystectomy: A 20-year experience
|
Douglawi, Antoin |
|
|
41 |
2 |
p. 107.e9-107.e14 |
artikel |
30 |
Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study
|
Ghoreifi, Alireza |
|
|
41 |
2 |
p. 111.e7-111.e14 |
artikel |
31 |
Seminar: Revisiting the value of PSA-based prostate cancer screening Essay No 5: Should men undergo MRI before prostate biopsy? (Pro)
|
Maffei, Davide |
|
|
41 |
2 |
p. 88-91 |
artikel |
32 |
Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?
|
de Jong, Florus C. |
|
|
41 |
2 |
p. 70-75 |
artikel |
33 |
Should grade group 1 prostate cancer be reclassified as “non-cancer”? A pathology community perspective
|
Zhou, Ming |
|
|
41 |
2 |
p. 62-64 |
artikel |
34 |
Should men undergo MRI before prostate biopsy – CON
|
Kim, Eric H. |
|
|
41 |
2 |
p. 92-95 |
artikel |
35 |
Table of Contents
|
|
|
|
41 |
2 |
p. ii-iv |
artikel |
36 |
The impact of local staging of prostate cancer determined on MRI or DRE at time of radical prostatectomy on progression-free survival: A Will Rogers phenomenon
|
Rakauskas, Arnas |
|
|
41 |
2 |
p. 106.e9-106.e16 |
artikel |
37 |
Variation in patient reported outcomes following radical prostatectomy: A bi-national registry-based study
|
O'Callaghan, Michael E. |
|
|
41 |
2 |
p. 105.e9-105.e18 |
artikel |